COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 2470: Articles 24691-24700  | Next

Humoral Response Dynamics Following Infection with SARS-CoV-2
Grandjean, L., Saso, A., Ortiz, A., Lam, T., Hatcher, J., Thistlethwaite, R., Harris, M., Best, T., Johnson, M., Wagstaffe, H., Ralph, E., Mai, A., Colijn, C., Breuer, J., Buckland, M., Gilmour, K., Goldblatt, D., The Co-Stars Study Team
10.1101/2020.07.16.20155663 — Posted: 2020-07-21
The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat raTG13
Liu, S., Selvaraj, P., Lien, C., Wu, W. W., Chou, C.-K., Wang, T.
10.1101/2020.07.20.213280 — Posted: 2020-07-21
Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2.
Johnson, M., Wagstaffe, H., Gilmour, K. C., Mai, A. L., Lewis, J., Hunt, A., Sirr, J., Bengt, C., Grandjean, L., Goldblatt, D.
10.1101/2020.07.20.213249 — Posted: 2020-07-21
SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB
Neufeldt, C. J., Cerikan, B., Cortese, M., Frankish, J., Lee, J.-Y., Plociennikowska, A., Heigwer, F., Joecks, S., Burkart, S. S., Zander, D. Y., Gendarme, M., El Debs, B., Halama, N., Merle, U., Boutros, M., Binder, M., Bartenschlager, R.
10.1101/2020.07.21.212639 — Posted: 2020-07-21 Discussion: Onsite | Offsite
S protein-reactive IgG and memory B cell production after human SARS-CoV-2 infection includes broad reactivity to the S2 subunit
Nguyen-Contant, P., Embong, A. K., Kanagaiah, P., Chaves, F., Yang, H., Branche, A. R., Topham, D. J., Sangster, M.
10.1101/2020.07.20.213298 — Posted: 2020-07-21
Integrative Vectors for Regulated Expression of SARS-CoV-2 Proteins Implicated in RNA Metabolism
Bresson, S., Robertson, N., Sani, E., Turowski, T. W., Shchepachev, V., Kompauerova, M., Spanos, C., Helwak, A., Tollervey, D.
10.1101/2020.07.20.211623 — Posted: 2020-07-21
Observational Study of the Efficiency of Treatments in Patients Hospitalized with Covid-19 in Madrid
Bernaola, N., Mena, R., Bernaola, A., Lara, A., Carballo, C., Larranaga, P., Bielza, C.
10.1101/2020.07.17.20155960 — Posted: 2020-07-21
Sleepless in Lockdown: unpacking differences in sleep loss during the coronavirus pandemicin the UK
Falkingham, J., Evandrou, M., Qin, M., Vlachantoni, A.
10.1101/2020.07.19.20157255 — Posted: 2020-07-21
A preliminary model to describe the transmission dynamics of Covid-19 between two neighboring cities or countries
Isea, R.
10.1101/2020.07.18.20156695 — Posted: 2020-07-21
The COVID-19 outbreak in Sichuan, China: epidemiology and impact of interventions
Liu, Q., Bento, A. I., Yang, K., Zhang, H., Yang, X., Merler, S., Vespignani, A., Lv, J., Yu, H., Zhang, W., Zhou, T., Ajelli, M.
10.1101/2020.07.20.20157602 — Posted: 2020-07-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).